{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:32:26Z","timestamp":1787614346696,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Nanjing Health Science and Technology Development Fund","award":["YKK17288"],"award-info":[{"award-number":["YKK17288"]}]},{"name":"the Jiangsu Commission of Health","award":["No. H201534"],"award-info":[{"award-number":["No. H201534"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-37698-2","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T11:34:54Z","timestamp":1770291294000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The utilization of CEUS and SWE for predicting pathological complete response to neoadjuvant chemotherapy for invasive breast cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Yingyan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanli","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyi","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiming","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyuan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danlu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danlei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"issue":"3","key":"37698_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74 (3), 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"37698_CR2","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1002\/cncr.29348","volume":"121","author":"SS Mougalian","year":"2015","unstructured":"Mougalian, S. S. et al. Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the united States. Cancer 121, 2544\u20132552 (2015).","journal-title":"Cancer"},{"key":"37698_CR3","doi-asserted-by":"crossref","unstructured":"Spring, L. M. et al. Pathological complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: a comprehensive meta-analysis. Clin Cancer Res 26  (12), 2838\u20132848 (2020).","DOI":"10.1158\/1078-0432.CCR-19-3492"},{"issue":"11","key":"37698_CR4","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1200\/JCO.2009.25.3286","volume":"28","author":"AS Caudle","year":"2010","unstructured":"Caudle, A. S. et al. Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer. J. Clin. Oncol. 28 (11), 1821\u20131828 (2010).","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"37698_CR5","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ijrobp.2020.04.044","volume":"108","author":"D Keilty","year":"2020","unstructured":"Keilty, D. et al. Patterns of recurrence and predictors of survival in breast cancer patients treated with neoadjuvant chemotherapy, surgery, and radiation. Int. J. Radiat. Oncol. Biol. Phys. 108 (3), 676\u2013685 (2020).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"37698_CR6","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin. 73 (1), 17\u201348 (2023).","journal-title":"CA Cancer J. Clin."},{"issue":"11","key":"37698_CR7","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1245\/s10434-011-1919-5","volume":"18","author":"R Croshaw","year":"2011","unstructured":"Croshaw, R., Shapiro-Wright, H., Svensson, E., Erb, K. & Julian, T. Accuracy of clinical examination, digital mammogram, ultrasound, and MRI in determining postneoadjuvant pathologic tumor response in operable breast cancer patients. Ann. Surg. Oncol. 18 (11), 3160\u20133163 (2011).","journal-title":"Ann. Surg. Oncol."},{"key":"37698_CR8","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1002\/cncr.33604","volume":"127","author":"BE Adrada","year":"2021","unstructured":"Adrada, B. E. et al. Early ultrasound evaluation identifies excellent responders to neoadjuvant systemic therapy among patients with triple-negative breast cancer. Cancer 127, 2880\u20132887 (2021).","journal-title":"Cancer"},{"issue":"7","key":"37698_CR9","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s00330-012-2446-x","volume":"22","author":"MO Leach","year":"2012","unstructured":"Leach, M. O. et al. Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging. Eur. Radiol. 22 (7), 1451\u20131464 (2012).","journal-title":"Eur. Radiol."},{"key":"37698_CR10","doi-asserted-by":"publisher","first-page":"3869538","DOI":"10.1155\/2020\/3869538","volume":"17","author":"X Leng","year":"2020","unstructured":"Leng, X., Huang, G., Zhang, L., Ding, J. & Ma, F. Changes in tumor stem cell markers and epithelial-mesenchymal transition markers in nonluminal breast cancer after neoadjuvant chemotherapy and their correlation with contrast-enhanced ultrasound. Biomed. Res. Int. 17, 3869538 (2020).","journal-title":"Biomed. Res. Int."},{"issue":"29","key":"37698_CR11","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1200\/JCO.2012.45.0940","volume":"31","author":"G Minckwitz","year":"2013","unstructured":"Minckwitz, G. et al. response-guided neoadjuvant chemotherapy for breast cancer. J. Clin. Oncol. 31 (29), 3623 (2013).","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"37698_CR12","first-page":"259","volume":"12","author":"SKR Kumar","year":"2020","unstructured":"Kumar, S. K. R., Thiyagarajan, M., Daniel, J. M. & Singh, K. B. A study on clinical and pathological responses to neoadjuvant chemotherapy in breast carcinoma. Breast Cancer. 12 (12), 259\u2013266 (2020).","journal-title":"Breast Cancer"},{"issue":"4","key":"37698_CR13","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1055\/a-0838-9937","volume":"40","author":"A S\u0103ftoiu","year":"2019","unstructured":"S\u0103ftoiu, A. et al. The EFSUMB guidelines and recommendations for the clinical practice of elastography in non-hepatic applications: update 2018. Ultraschall Med. 40 (4), 425\u2013453 (2019).","journal-title":"Ultraschall Med."},{"issue":"5","key":"37698_CR14","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00330-011-2340-y","volume":"22","author":"DO Cosgrove","year":"2012","unstructured":"Cosgrove, D. O. et al. Shear wave elastography for breast masses is highly reproducible. Eur. Rad. 22 (5), 1023\u20131032 (2012).","journal-title":"Eur. Rad"},{"issue":"3","key":"37698_CR15","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s12282-021-01327-9","volume":"29","author":"J Gu","year":"2022","unstructured":"Gu, J., He, C., Zhao, Q. & Jiang, T. Usefulness of new shear wave elastography in early predicting the efficacy of neoadjuvant chemotherapy for patients with breast cancer: where and when to measure is optimal? Breast Cancer. 29 (3), 478\u2013486 (2022).","journal-title":"Breast Cancer"},{"key":"37698_CR16","doi-asserted-by":"publisher","first-page":"1320714","DOI":"10.3389\/fonc.2024.1320714","volume":"14","author":"L Li","year":"2024","unstructured":"Li, L. et al. Contrast-enhanced ultrasound for the preoperative prediction of pathological characteristics in breast cancer. Front. Oncol. 14, 1320714 (2024).","journal-title":"Front. Oncol."},{"issue":"1","key":"37698_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13058-018-0975-1","volume":"20","author":"Q Zhu","year":"2018","unstructured":"Zhu, Q. et al. Identifying an early treatment window for predicting breast cancer response to neoadjuvant chemotherapy using immunohistopathology and hemoglobin parameters. Breast Cancer Res. 20 (1), 56 (2018).","journal-title":"Breast Cancer Res."},{"issue":"1","key":"37698_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12094-019-02112-z","volume":"22","author":"Y Zhao","year":"2020","unstructured":"Zhao, Y., Wang, X., Huang, Y., Zhou, X. & Zhang, D. Response to immunohistochemical markers\u2019 conversion after neoadjuvant chemotherapy in breast cancer patients: association between imaging and histopathologic analysis. Clin. Transl Oncol. 22 (1), 91\u2013102 (2020).","journal-title":"Clin. Transl Oncol."},{"issue":"8","key":"37698_CR19","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1016\/j.ultrasmedbio.2021.03.039","volume":"47","author":"J Gu","year":"2021","unstructured":"Gu, J. et al. Prediction of invasive breast cancer using mass characteristic frequency and elasticity in correlation with prognostic histologic features and immunohistochemical biomarkers. Ultrasound Med. Biol. 47 (8), 2193\u20132201 (2021).","journal-title":"Ultrasound Med. Biol."},{"key":"37698_CR20","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ejrad.2018.04.005","volume":"103","author":"C Wan","year":"2018","unstructured":"Wan, C. et al. Quantitative contrast-enhanced ultrasound evaluation of pathological complete response in patients with locally advanced breast cancer receiving neoadjuvant chemotherapy. Eur. J. Radiol. 103, 118\u2013123 (2018).","journal-title":"Eur. J. Radiol."},{"issue":"5","key":"37698_CR21","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0960-9776(03)00106-1","volume":"12","author":"KN Ogston","year":"2003","unstructured":"Ogston, K. N. et al. A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival. Breast 12 (5), 320\u2013327 (2003).","journal-title":"Breast"},{"issue":"2","key":"37698_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/01.sla.0000197714.14318.6f","volume":"243","author":"AB Chagpar","year":"2006","unstructured":"Chagpar, A. B. et al. Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy. Ann. Surg. 243 (2), 257\u2013264 (2006).","journal-title":"Ann. Surg."},{"key":"37698_CR23","doi-asserted-by":"publisher","first-page":"816297","DOI":"10.3389\/fonc.2022.816297","volume":"12","author":"X Kong","year":"2022","unstructured":"Kong, X. et al. Advances in imaging in evaluating the efficacy of neoadjuvant chemotherapy for breast cancer. Front. Oncol. 12, 816297 (2022).","journal-title":"Front. Oncol."},{"key":"37698_CR24","doi-asserted-by":"publisher","first-page":"1255618","DOI":"10.3389\/fonc.2024.1255618","volume":"14","author":"J Zhang","year":"2024","unstructured":"Zhang, J. et al. Monitoring response to neoadjuvant therapy for breast cancer in all treatment phases using an ultrasound deep learning model. Front. Oncol. 14, 1255618 (2024).","journal-title":"Front. Oncol."},{"key":"37698_CR25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejca.2021.01.028","volume":"147","author":"M Jiang","year":"2021","unstructured":"Jiang, M. et al. Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer. Eur. J. Cancer. 147, 95\u2013105 (2021).","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"37698_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1055\/s-2006-927226","volume":"28","author":"P Ricci","year":"2007","unstructured":"Ricci, P. et al. Benign and malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging. Ultraschall Med. 28 (1), 57\u201362 (2007).","journal-title":"Ultraschall Med."},{"issue":"15","key":"37698_CR27","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.7150\/jca.44313","volume":"11","author":"CO Madu","year":"2020","unstructured":"Madu, C. O., Wang, S., Madu, C. O. & Lu, Y. Angiogenesis in breast cancer progression, diagnosis, and treatment. J. Cancer. 11 (15), 4474\u20134494 (2020).","journal-title":"J. Cancer"},{"issue":"4","key":"37698_CR28","doi-asserted-by":"publisher","first-page":"945","DOI":"10.21873\/invivo.11333","volume":"32","author":"I Vraka","year":"2018","unstructured":"Vraka, I. et al. Correlation between contrast-enhanced ultrasound characteristics (qualitative and quantitative) and pathological prognostic factors in breast cancer. Vivo 32 (4), 945\u2013954 (2018).","journal-title":"Vivo"},{"issue":"2","key":"37698_CR29","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer, E. A. et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur. J. Cancer. 45 (2), 228\u2013247 (2009).","journal-title":"Eur. J. Cancer"},{"key":"37698_CR30","doi-asserted-by":"publisher","first-page":"109025","DOI":"10.1016\/j.ejrad.2020.109025","volume":"128","author":"AM Maier","year":"2020","unstructured":"Maier, A. M. et al. Prediction of pathological complete response in breast cancer patients during neoadjuvant chemotherapy: is shear wave elastography a useful tool in clinical routine? Eur. J. Radiol. 128, 109025 (2020).","journal-title":"Eur. J. Radiol."},{"issue":"9","key":"37698_CR31","first-page":"1083","volume":"29","author":"J Zhu","year":"2014","unstructured":"Zhu, J., Xiong, G., Trinkle, C. & Xu, R. Integrated extracellular matrix signaling in mammary gland development and breast cancer progression. Histol. Histopathol. 29 (9), 1083\u20131092 (2014).","journal-title":"Histol. Histopathol"},{"issue":"8","key":"37698_CR32","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.7863\/ultra.15.08052","volume":"35","author":"H Jing","year":"2016","unstructured":"Jing, H. et al. Early evaluation of relative changes in tumor stiffness by shear wave elastography predicts the response to neoadjuvant chemotherapy in patients with breast cancer. J. Ultrasound Med. 35 (8), 1619\u20131627 (2016).","journal-title":"J. Ultrasound Med."},{"issue":"4","key":"37698_CR33","first-page":"422","volume":"9","author":"A Evans","year":"2018","unstructured":"Evans, A. et al. Prediction of pathological complete response to neoadjuvant chemotherapy for primary breast cancer comparing interim ultrasound, shear wave elastography and MRI. Ultraschall Med. 9 (4), 422\u2013431 (2018).","journal-title":"Ultraschall Med."},{"issue":"2","key":"37698_CR34","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s00330-023-10057-9","volume":"34","author":"X Jinshun","year":"2023","unstructured":"Jinshun, X. et al. Evaluation of standard breast ultrasonography by adding two-dimensional and three-dimensional shear wave elastography: a prospective, multicenter trial. Eur. Radiol. 34 (2), 945\u2013956 (2023).","journal-title":"Eur. Radiol."},{"issue":"4","key":"37698_CR35","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/hep.24108","volume":"53","author":"J Schrader","year":"2011","unstructured":"Schrader, J. et al. Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells. Hepatology 53 (4), 1192\u20131205 (2011).","journal-title":"Hepatology"},{"issue":"5","key":"37698_CR36","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","volume":"139","author":"KR Levental","year":"2009","unstructured":"Levental, K. R. et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139 (5), 891\u2013906 (2009).","journal-title":"Cell"},{"key":"37698_CR37","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ejca.2016.03.006","volume":"60","author":"R Gahlaut","year":"2016","unstructured":"Gahlaut, R. et al. Effect of neoadjuvant chemotherapy on breast cancer phenotype, ER\/PR and HER2 expression - implications for the practising oncologist. Eur. J. Cancer. 60, 40\u201348 (2016).","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"37698_CR38","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1097\/SLA.0000000000000924","volume":"260","author":"JC Boughey","year":"2014","unstructured":"Boughey, J. C. et al. Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) prospective multicenter clinical Trial[J]. Ann. Surg. 260 (4), 608\u2013614 (2014).","journal-title":"Ann. Surg."},{"issue":"89","key":"37698_CR39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.15557\/JoU.2022.0016","volume":"22","author":"K Dobruch-Sobczak","year":"2022","unstructured":"Dobruch-Sobczak, K., Gumowska, M., M\u0105czewska, J., Kolasi\u0144ska-\u0106wik\u0142a, A. & Guzik, P. Immunohistochemical subtypes of the breast cancer in the ultrasound and clinical aspect - literature review. J. Ultrason. 22 (89), 93\u201399 (2022).","journal-title":"J. Ultrason."},{"issue":"9","key":"37698_CR40","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1002\/jum.14564","volume":"37","author":"SH Yeo","year":"2018","unstructured":"Yeo, S. H., Kim, G. R., Lee, S. H. & Moon, W. K. Comparison of ultrasound elastography and color doppler ultrasonography for distinguishing small triple-negative breast cancer from fibroadenoma. J. Ultrasound Med. 37 (9), 2135\u20132146 (2018).","journal-title":"J. Ultrasound Med."},{"issue":"5","key":"37698_CR41","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.21037\/qims-22-910","volume":"13","author":"Y Duan","year":"2023","unstructured":"Duan, Y. et al. Comparative study of pathological response evaluation systems after neoadjuvant chemotherapy for breast cancer: developing predictive models of multimodal ultrasound features including shear wave elastography combined with puncture pathology. Quant. Imaging Med. Surg. 13 (5), 3013\u20133028 (2023).","journal-title":"Quant. Imaging Med. Surg."},{"issue":"9938","key":"37698_CR42","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","volume":"384","author":"P Cortazar","year":"2014","unstructured":"Cortazar, P. et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet 384 (9938), 164\u2013172 (2014).","journal-title":"Lancet"},{"key":"37698_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40644-024-00662-2","volume":"24","author":"X Yan","year":"2024","unstructured":"Yan, X. et al. Development and validation of a nomogram model based on pretreatment ultrasound and contrast-enhanced ultrasound to predict the efficacy of neoadjuvant chemotherapy in patients with borderline resectable or locally advanced pancreatic cancer. Cancer Imaging. 24, 13 (2024).","journal-title":"Cancer Imaging"},{"issue":"6","key":"37698_CR44","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1124\/mol.116.106765","volume":"90","author":"HE Majeski","year":"2016","unstructured":"Majeski, H. E. & Yang, J. The 2016 John J. Abel award lecture: targeting the mechanical microenvironment in cancer. Mol. Pharmacol. 90 (6), 744\u2013754 (2016).","journal-title":"Mol. Pharmacol."},{"key":"37698_CR45","doi-asserted-by":"publisher","first-page":"603574","DOI":"10.3389\/fonc.2020.603574","volume":"10","author":"J Zhang","year":"2020","unstructured":"Zhang, J. et al. A novel model incorporating tumor stiffness, blood flow characteristics, and ki-67 expression to predict responses after neoadjuvant chemotherapy in breast cancer. Front. Oncol. 10, 603574 (2020).","journal-title":"Front. Oncol."},{"issue":"5","key":"37698_CR46","doi-asserted-by":"publisher","first-page":"773","DOI":"10.7863\/jum.2012.31.5.773","volume":"31","author":"RG Barr","year":"2012","unstructured":"Barr, R. G. Sonographic breast elastography: a primer. J. Ultrasound Med. 31 (5), 773\u2013783 (2012).","journal-title":"J. Ultrasound Med."},{"issue":"3 Suppl","key":"37698_CR47","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1245\/s10434-015-4828-1","volume":"22","author":"SH Lee","year":"2015","unstructured":"Lee, S. H. et al. Shear-wave elastography for the detection of residual breast cancer after neoadjuvant chemotherapy. Ann. Surg. Oncol. 22 (3 Suppl), 376\u2013384 (2015).","journal-title":"Ann. Surg. Oncol."},{"issue":"7","key":"37698_CR48","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/j.ultrasmedbio.2023.03.017","volume":"49","author":"Y Xie","year":"2023","unstructured":"Xie, Y. et al. Early prediction of response to neoadjuvant chemotherapy using quantitative parameters on automated breast ultrasound combined with contrast-enhanced ultrasound in breast cancer. Ultrasound Med. Biol. 49 (7), 1638\u20131646 (2023).","journal-title":"Ultrasound Med. Biol."},{"key":"37698_CR49","doi-asserted-by":"publisher","first-page":"111432","DOI":"10.1016\/j.ejrad.2024.111432","volume":"175","author":"EJ Lee","year":"2024","unstructured":"Lee, E. J. & Chang, Y. Prediction of complete response after neoadjuvant chemotherapy for invasive breast cancers: the utility of shear wave elastography and Superb microvascular imaging in pretreatment breast ultrasound. Eur. J. Radiol. 175, 111432 (2024).","journal-title":"Eur. J. Radiol."},{"issue":"2","key":"37698_CR50","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1002\/cam4.5019","volume":"12","author":"X Han","year":"2023","unstructured":"Han, X. et al. Prediction of pathological complete response to neoadjuvant chemotherapy in patients with breast cancer using a combination of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging. Cancer Med. 12 (2), 1389\u20131398 (2023).","journal-title":"Cancer Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37698-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37698-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37698-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T22:04:04Z","timestamp":1771884244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37698-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["37698"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-37698-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"28 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7434"}}